|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-8-15
|
|
pubmed:abstractText |
MOC-31 is an established immunologic marker with which to detect adenocarcinomas. The objective of the current study was to evaluate the use of MOC-31 in the diagnosis of metastatic adenocarcinoma in effusion specimens.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1934-6638
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2011 American Cancer Society.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
25
|
|
pubmed:volume |
119
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
272-8
|
|
pubmed:meshHeading |
pubmed-meshheading:21732548-Adenocarcinoma,
pubmed-meshheading:21732548-Antibodies, Monoclonal,
pubmed-meshheading:21732548-Cell Membrane,
pubmed-meshheading:21732548-Diagnosis, Differential,
pubmed-meshheading:21732548-Humans,
pubmed-meshheading:21732548-Immunoenzyme Techniques,
pubmed-meshheading:21732548-Mesothelioma,
pubmed-meshheading:21732548-Neoplasms,
pubmed-meshheading:21732548-Tumor Markers, Biological
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Use of the monoclonal antibody MOC-31 as an immunomarker for detecting metastatic adenocarcinoma in effusion cytology.
|
|
pubmed:affiliation |
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.
|
|
pubmed:publicationType |
Journal Article
|
